Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MCK | Ann: MCK 2025 ASM Voting Results | 13:04 | 0 | 123 | |||
|
|||||||
MCK | Ann: MCK 2025 ASM Speech Notes and Presentation Slides | 10:34 | 0 | 121 | |||
|
|||||||
MCK | Ann: MCK Dividend for FY2024 | 10:26 | 0 | 133 | |||
|
|||||||
MCK | Ann: SPH Notice - CDL Hotels Holdings New Zealand Limited | 16/05/25 | 0 | 123 | |||
|
|||||||
MCK | Ann: Amended Notice of Annual Meeting 2025 | 13/05/25 | 0 | 119 | |||
|
|||||||
MCK | Ann: Takeover offer closed - compulsory acquisition not reached | 09/05/25 | 0 | 124 | |||
|
|||||||
MCK | Ann: SPH Notice - CDL Hotels Holdings New Zealand Limited | 09/05/25 | 0 | 97 | |||
|
|||||||
MCK | Ann: SPH Notice - CDL Hotels Holdings New Zealand Limited | 05/05/25 | 0 | 103 | |||
|
See All Discussions